Sarah Mostardt

405 total citations
25 papers, 295 citations indexed

About

Sarah Mostardt is a scholar working on Economics and Econometrics, Epidemiology and General Health Professions. According to data from OpenAlex, Sarah Mostardt has authored 25 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 7 papers in Epidemiology and 6 papers in General Health Professions. Recurrent topics in Sarah Mostardt's work include Health and Medical Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and HIV-related health complications and treatments (4 papers). Sarah Mostardt is often cited by papers focused on Health and Medical Studies (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and HIV-related health complications and treatments (4 papers). Sarah Mostardt collaborates with scholars based in Germany, United States and Switzerland. Sarah Mostardt's co-authors include Anja Neumann, Jürgen Wasem, Janine Biermann, Till Neumann, Götz Gelbrich, Hans‐Christoph Diener, Oliver Müller, Andreas Gerber‐Grote, Charly Gaul and Norbert H. Brockmeyer and has published in prestigious journals such as Journal of Clinical Epidemiology, Cephalalgia and Value in Health.

In The Last Decade

Sarah Mostardt

24 papers receiving 293 citations

Peers

Countries citing papers authored by Sarah Mostardt

Since Specialization

Citations

This map shows the geographic impact of Sarah Mostardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Mostardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Mostardt more than expected).

Fields of papers citing papers by Sarah Mostardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Mostardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Mostardt. The network helps show where Sarah Mostardt may publish in the future.

Co-authorship network of co-authors of Sarah Mostardt

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Mostardt. A scholar is included among the top collaborators of Sarah Mostardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Mostardt. Sarah Mostardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer 2020 ·The European Journal of Health Economics ·(unknown), (unknown), (unknown), Sarah Mostardt, M. Ripoll, (unknown), Sara Schiller, (unknown)	1
2	The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds? 2018 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Frank Sandmann, Sarah Mostardt, Stefan K. Lhachimi, Andreas Gerber‐Grote	10
3	Checkliste zur Erstellung und Bewertung von Krankheitskostenstudien 2017 ·Das Gesundheitswesen ·Dirk Müller, Stephanie Stock, Charalabos‐Markos Dintsios, (unknown), Andreas Gerber‐Grote, (unknown), (unknown), E Huppertz, (unknown), Sarah Mostardt, Juliane Köberlein–Neu, Anne Prenzler, Hans Joachim Salize, Sara Santos, (unknown), (unknown), (unknown), Andrea Icks	13
4	No suitable precise or optimized epidemiologic search filters were available for bibliographic databases 2016 ·Journal of Clinical Epidemiology ·Siw Waffenschmidt, (unknown), Andreas Gerber‐Grote, Sarah Mostardt	9
5	Evaluation of an integrated care program for schizophrenia: concept and study design 2014 ·European Archives of Psychiatry and Clinical Neuroscience ·(unknown), Sarah Mostardt, Janine Biermann, Jürgen Wasem, Anja Neumann, (unknown), (unknown), Claudia Bartels, Peter Falkai, Werner Brannath, (unknown), (unknown), J. Timm, Thomas Wobrock	7
6	Decision making in Germany: Is health economic evaluation as a supporting tool a sleeping beauty? 2014 ·Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen ·Andreas Gerber‐Grote, Frank Sandmann, Min Zhou, (unknown), (unknown), (unknown), (unknown), Alexander Mensch, Sarah Mostardt, (unknown), Stefan K. Lhachimi	14
7	Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study 2014 ·Clinical Research in Cardiology ·Anja Neumann, Sarah Mostardt, Janine Biermann, Götz Gelbrich, Alexander Goehler, Benjamin P. Geisler, Uwe Siebert, Stefan Störk, Georg Ertl, (unknown), Jürgen Wasem	16
8	Standard Costs for Health Economic Evaluations: An International Comparison 2014 ·Value in Health ·Sarah Mostardt, Frank Sandmann, (unknown), Min Zhou, Andreas Gerber‐Grote	3
9	Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia 2013 ·Clinical Research in Cardiology ·(unknown), Raoul Stahrenberg, Klaus Gröschel, Sarah Mostardt, Janine Biermann, Frank Edelmann, Jan Liman, Jürgen Wasem, Alexander Goehler, Rolf Wachter, Anja Neumann	11
10	Bestandsaufnahme zu Versorgungsdefiziten und Versorgungsmanagementprogrammen bei Multiple Sklerose in Deutschland 2013 ·Das Gesundheitswesen ·(unknown), (unknown), Sarah Mostardt, (unknown), Jürgen Wasem, (unknown)	1
11	Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men 2013 ·European Journal of Preventive Cardiology ·(unknown), Till Neumann, Jennifer Manne‐Goehler, Janet Lo, Anja Neumann, Sarah Mostardt, Suhny Abbara, Udo Hoffmann, Thomas J. Brady, Jürgen Wasem, Steven Grinspoon, G. Scott Gazelle, Alexander Goehler	12
12	Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study 2012 ·The European Journal of Health Economics ·Sarah Mostardt, (unknown), Jürgen Wasem, (unknown), Knud Schewe, Eva Wolf, Christoph Mayr, Hans Jaeger, Holger Pfaff, S Dupke, Anja Neumann	22
13	Wirksamkeit und Kostenwirksamkeit eines Case-Management-Programms bei Patienten mit Demenz 2012 ·Zeitschrift für Gerontologie und Geriatrie ·Sarah Mostardt, (unknown), W. Schröer, Jürgen Wasem, Anja Neumann	9
14	Cost of HIV and determinants of health care costs in HIV-positive patients in Germany – Results of the DAGNÄ K3A Study 2011 ·Das Gesundheitswesen ·Sarah Mostardt, (unknown), Jürgen Wasem, Andreas Goetzenich, Knud Schewe, Christoph Mayr, (unknown), Eva Wolf, S Dupke, Axel A. Neumann	1
15	Treatment costs and indirect costs of cluster headache: A health economics analysis 2011 ·Cephalalgia ·Charly Gaul, (unknown), Janine Biermann, Sarah Mostardt, Hans‐Christoph Diener, Oliver Müller, Jürgen Wasem, Anja Neumann	62
16	Lipodystrophy – a sign for metabolic syndrome in patients of the HIV‐HEART study 2010 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Anja Potthoff, Norbert H. Brockmeyer, Götz Gelbrich, Kathrin Neuhaus, Stefan Eßer, Nico Reinsch, Martin Hower, Sarah Mostardt, Anja Neumann, Till Neumann	8
17	Schätzung der Ausgaben der öffentlichen Hand durch den Konsum illegaler Drogen in Deutschland 2010 ·Das Gesundheitswesen ·Sarah Mostardt, (unknown), Anja Neumann, Jürgen Wasem, Tim Pfeiffer-Gerschel	10
18	Lipodystrophie als Hinweis für das metabolische Syndrom bei Patienten der HIV‐HEART‐Studie 2010 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Anja Potthoff, Norbert H. Brockmeyer, Götz Gelbrich, Kathrin Neuhaus, Stefan Eßer, Nico Reinsch, Martin Hower, Sarah Mostardt, Anja Neumann, Till Neumann, (unknown)	4
19	Kosteneffektivität des Einsatzes von Studienschwestern in der Betreuung von Patienten mit Herzinsuffizienz 2010 ·Herz ·Janine Biermann, Sarah Mostardt, Till Neumann, (unknown), Jürgen Wasem, Anja Neumann, (unknown)	3
20	Wertigkeit des Biomarkers BNP bei HIV-infizierten Patienten 2009 ·Herz ·(unknown), Till Neumann, Nico Reinsch, Kathrin Neuhaus, Norbert H. Brockmeyer, Anja Potthoff, Stefan Eßer, Martin Hower, Anja Neumann, Sarah Mostardt, Götz Gelbrich, Raimund Erbel	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact